Strategies for determining correct cytochrome P450 contributions in hepatic clearance predictions : in vitro-in vivo extrapolation as modelling approach and tramadol as proof-of concept compound
2017) EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 42(3). p.537-543 Mark(
- Enzymatic tumour tissue digestion coupled to SPE-UPLC–tandem mass spectrometry as a tool to explore paclitaxel tumour penetration
- Pharmacokinetics in children with liver disease: can ex vivo obtained population-specific CYP450 characteristics bridge the knowledge gap?
- In vitro cytochrome P450 activity decreases in children with high paediatric end-stage liver disease scores
- Hypervariable cytochrome P450 activity in children with severe hepatic dysfunction